FDA Clearance Tracker · P890047
PROVISC(TM)VISCOELASTIC PREPARATION
Last checked: Nov 20, 2026Latest source record: Sep 26, 1991 (this decision)Source: openFDAMethods & limitations
Decided
Sep 26, 1991
Approved
Time to decision
764 days
Received Aug 23, 1989. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA
Device class
Class III
The decision
- FDA number
- P890047
- Device name
- PROVISC(TM)VISCOELASTIC PREPARATION
- Applicant
- Alcon Research, Ltd.
- Applicant location
- Fort Worth, TX
- Received
- Aug 23, 1989
- Decided
- Sep 26, 1991
- Decision
- Approved
- Supplements
- 68 in FDA's data for this PMA. See them on the FDA record
Device type
- Device type
- AID, SURGICAL, VISCOELASTIC (LZP)
- Device class
- Class III
- Regulation
- 21 CFR 886.4275
- Specialty
- Ophthalmology
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code LZP. The earliest in FDA's data is P810031, decided Jan 14, 1983.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
Other decisions for Alcon Research, Ltd.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- AcrySof IQ PanOptix Trifocal Intraocular Lens and AcrySof IQ PanOptix Toric Trifocal Intraocular LensPMA supplement
P040020-S087 · Decided Aug 26, 2019 · 207 days after receipt · Panel Track
Device type: Lens, multifocal intraocular (MFK) · Ophthalmology
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.